SCHEMBL985564

SCHEMBL985564

CCCCNC(=O)C(CNC(=O)CCC)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASAH1 Q13510 2/20 0.54
KDM4A O75164 1/20 0.54
NAAA Q02083 2/20 0.53
LMNA P02545 1/20 0.53
PAX8 Q06710 1/20 0.53
POLB P06746 1/20 0.50
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
HPGD P15428 1/20 0.48
MEN1 O00255 1/20 0.47
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 1/20 0.47
ACER2 Q5QJU3 1/20 0.47
CHRNB2 P17787 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA4 P43681 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL988168 0.96 NAAA (0.59) ASAH1KDM4ANAAALMNAPAX8
SCHEMBL988138 0.92 POLB (0.52) ASAH1KDM4ANAAALMNAPAX8
SCHEMBL988509 0.87 ASAH1 (0.51) ASAH1KDM4APOLBCYP3A4CYP2C19
SCHEMBL989842 0.85 ASAH1 (0.51) ASAH1KDM4ALMNAPOLBCYP3A4
SCHEMBL987677 0.80 ASAH1 (0.52) ASAH1CYP3A4CYP2C19HPGDALDH1A1
SCHEMBL27094297 0.80 ASAH1 (0.52) ASAH1CYP3A4CYP2C19HPGDALDH1A1
SCHEMBL6436285 0.76 CNR1 (0.69) NAAALMNAPAX8CYP3A4CYP2D6
SCHEMBL5497841 0.76 KDM4A (0.43) ASAH1KDM4ANAAALMNAPOLB
SCHEMBL5494963 0.76 KDM4A (0.43) ASAH1KDM4ANAAALMNAPOLB
SCHEMBL6646425 0.75 ASAH1 (0.68) ASAH1POLBHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4322935-A1 AMIDE DERIVATIVES OF BUTYRIC ACID FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION Rhea Innovations S.R.L. (IT) 2024-02-21 EP claimed
WO-2022219020-A1 AMIDE DERIVATIVES OF BUTYRIC ACID FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION RHEA INNOVATIONS S.R.L. (IT) 2022-10-20 WO claimed
EP-2268605-A1 FATTY ACID DERIVATIVES FOR ORAL ADMINISTRATION ENDOWED WITH HIGH PAIA- TABILITY Berni Canani, Roberto (IT) 2011-01-05 EP claimed
WO-2009130735-A1 FATTY ACID DERIVATIVES FOR ORAL ADMINISTRATION ENDOWED WITH HIGH PALATABILITY BERNI CANANI ROBERTO (IT) 2009-10-29 WO claimed
WO-2026099710-A1 NUTRITIONAL COMPOSITION AND THERAPEUTIC OR PREVENTIVE USE THEREOF NUTRITECHLAB S.R.L.S. (IT) 2026-05-15 WO disclosed
EP-4322935-A1 AMIDE DERIVATIVES OF BUTYRIC ACID FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION Rhea Innovations S.R.L. (IT) 2024-02-21 EP disclosed
WO-2022219020-A1 AMIDE DERIVATIVES OF BUTYRIC ACID FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION RHEA INNOVATIONS S.R.L. (IT) 2022-10-20 WO disclosed
EP-2268605-A1 FATTY ACID DERIVATIVES FOR ORAL ADMINISTRATION ENDOWED WITH HIGH PAIA- TABILITY Berni Canani, Roberto (IT) 2011-01-05 EP disclosed
WO-2009130735-A1 FATTY ACID DERIVATIVES FOR ORAL ADMINISTRATION ENDOWED WITH HIGH PALATABILITY BERNI CANANI ROBERTO (IT) 2009-10-29 WO disclosed